Home > Share Market > Stocks > Bal pharma > Financial Statements> BALPHARMA Profit & Loss

Bal Pharma Ltd Financial Statements

Profit & Loss Statement of Bal Pharma Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 251 171 209 229
yoy growth (%) 46.40 (18) (8.60) 15.40
Raw materials (151) (84) (99) (116)
As % of sales 60.30 49.20 47.30 50.80
Employee costs (42) (50) (47) (45)
As % of sales 16.70 29.50 22.50 19.80
Other costs (33) (32) (46) (53)
As % of sales 13.30 18.60 21.90 22.90
Operating profit 24.50 4.76 17.20 14.80
OPM 9.76 2.78 8.23 6.47
Depreciation (9.50) (7.70) (6.80) (6.50)
Interest expense (12) (12) (9.30) (8.50)
Other income 1.14 1.84 1.70 3.04
Profit before tax 4.10 (14) 2.88 2.87
Taxes 0.61 0.64 (2.50) (3.30)
Tax rate 14.90 (4.70) (87) (114)
Minorities and other 0.03 0.67 2.41 2.15
Adj. profit 4.74 (12) 2.78 1.76
Exceptional items -- -- -- --
Net profit 4.74 (12) 2.78 1.76
yoy growth (%) (139) (539) 58.30 25
NPM 1.89 (7.10) 1.33 0.77

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000